INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $455,268 | +9.4% | 11,164 | -0.0% | 0.26% | +3.1% |
Q1 2023 | $416,269 | +6.8% | 11,169 | -0.0% | 0.26% | +2.4% |
Q4 2022 | $389,826 | -37.6% | 11,173 | 0.0% | 0.25% | -44.2% |
Q3 2022 | $625,000 | +10.2% | 11,173 | +2.0% | 0.45% | +20.6% |
Q2 2022 | $567,000 | – | 10,956 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |